|
|
protein dna complex disassembly
|
GO:0032986 |
1 |
1.000
|
Human |
|
|
nucleosome disassembly
|
GO:0006337 |
1 |
1.000
|
Human |
|
|
chromatin disassembly
|
GO:0031498 |
1 |
1.000
|
Human |
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
1.000
|
|
|
|
regulation of transcription during meiosis
|
GO:0051037 |
1 |
1.000
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
1.000
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
1.000
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.999
|
|
|
|
histone h3 acetylation
|
GO:0043966 |
14 |
0.998
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
28 |
0.998
|
Human |
|
|
blastocyst growth
|
GO:0001832 |
23 |
0.997
|
|
|
|
negative regulation of chromatin silencing
|
GO:0031936 |
1 |
0.996
|
|
|
|
regulation of chromatin silencing
|
GO:0031935 |
2 |
0.995
|
|
|
|
chromatin assembly or disassembly
|
GO:0006333 |
16 |
0.994
|
Human |
|
|
maintenance of chromatin silencing
|
GO:0006344 |
2 |
0.994
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.993
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.991
|
|
|
|
protein complex disassembly
|
GO:0043241 |
40 |
0.991
|
Human |
|
|
protein deacetylation
|
GO:0006476 |
32 |
0.991
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.989
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.989
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
3 |
0.988
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.988
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.988
|
|
|
|
dna methylation
|
GO:0006306 |
43 |
0.987
|
|
|
|
histone h4 acetylation
|
GO:0043967 |
10 |
0.979
|
|
|
|
macromolecule deacylation
|
GO:0098732 |
37 |
0.976
|
|
|
|
histone deubiquitination
|
GO:0016578 |
2 |
0.971
|
|
|
|
stem cell fate specification
|
GO:0048866 |
3 |
0.971
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.970
|
|
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
2 |
0.969
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.966
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.963
|
|
|
|
peptidyl lysine methylation
|
GO:0018022 |
29 |
0.962
|
|
|
|
regulation of protein deacetylation
|
GO:0090311 |
17 |
0.962
|
|
|
|
dna alkylation
|
GO:0006305 |
43 |
0.960
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.955
|
|
|
|
histone h4 k16 acetylation
|
GO:0043984 |
3 |
0.953
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.953
|
|
|
|
dna methylation on cytosine
|
GO:0032776 |
5 |
0.952
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.952
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.948
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.946
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.943
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.943
|
|
|
|
regulation of cell cycle g2 m phase transition
|
GO:1902749 |
10 |
0.939
|
|
|
|
oligosaccharide catabolic process
|
GO:0009313 |
2 |
0.933
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.929
|
|
|
|
neuroblast fate commitment
|
GO:0014017 |
1 |
0.927
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.927
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.922
|
Worm |
|
|
histone h4 deacetylation
|
GO:0070933 |
4 |
0.917
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.917
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.912
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.912
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.911
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.906
|
|
|
|
histone deacetylation
|
GO:0016575 |
26 |
0.877
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.876
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.867
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.862
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.859
|
|
|
|
gonad morphogenesis
|
GO:0035262 |
1 |
0.855
|
|
|
|
protein deacylation
|
GO:0035601 |
36 |
0.854
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.853
|
|
|
|
blastocyst hatching
|
GO:0001835 |
4 |
0.853
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.849
|
|
|
|
macromolecular complex disassembly
|
GO:0032984 |
43 |
0.841
|
Human |
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.837
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.834
|
|
|
|
single species biofilm formation
|
GO:0044010 |
1 |
0.834
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.832
|
|
|
|
dna modification
|
GO:0006304 |
50 |
0.830
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.830
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.824
|
|
|
|
negative regulation of gene expression epigenetic
|
GO:0045814 |
15 |
0.801
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.801
|
|
|
|
definitive erythrocyte differentiation
|
GO:0060318 |
7 |
0.801
|
|
|
|
chromatin remodeling
|
GO:0006338 |
32 |
0.797
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.795
|
|
|
|
glial cell fate determination
|
GO:0007403 |
3 |
0.795
|
|
|
|
histone h3 k14 acetylation
|
GO:0044154 |
3 |
0.795
|
|
|
|
biofilm formation
|
GO:0042710 |
1 |
0.793
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.793
|
|
|
|
negative regulation of transcription from rna polymerase i promoter
|
GO:0016479 |
2 |
0.785
|
|
|
|
atp dependent chromatin remodeling
|
GO:0043044 |
9 |
0.780
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.774
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.767
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.759
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.758
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.758
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.747
|
|
|
|
chromatin silencing at rdna
|
GO:0000183 |
3 |
0.741
|
|
|
|
nucleosome positioning
|
GO:0016584 |
4 |
0.739
|
|
|
|
regulation of neuroblast proliferation
|
GO:1902692 |
27 |
0.734
|
|
|
|
histone h3 k4 trimethylation
|
GO:0080182 |
5 |
0.731
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.727
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.724
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.724
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.705
|
Worm |
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.698
|
|
|
|
chromatin assembly
|
GO:0031497 |
13 |
0.696
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.678
|
|
|
|
cell fate determination
|
GO:0001709 |
32 |
0.657
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.654
|
|
|
|
interaction with symbiont
|
GO:0051702 |
14 |
0.646
|
|
|
|
positive regulation of chromatin binding
|
GO:0035563 |
3 |
0.646
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.645
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.642
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.641
|
|
|
|
regulation of viral transcription
|
GO:0046782 |
3 |
0.627
|
|
|
|
chromatin remodeling at centromere
|
GO:0031055 |
2 |
0.618
|
|
|
|
positive regulation of binding
|
GO:0051099 |
49 |
0.610
|
|
|
|
peptidyl lysine trimethylation
|
GO:0018023 |
12 |
0.608
|
|
|
|
chromatin mediated maintenance of transcription
|
GO:0048096 |
2 |
0.607
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.604
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.600
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.599
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.587
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.577
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.576
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.572
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.569
|
|
|
|
negative regulation of gene silencing
|
GO:0060969 |
2 |
0.562
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.554
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.552
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.537
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0043618 |
8 |
0.525
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.517
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.507
|
|
|
|
viral gene expression
|
GO:0019080 |
3 |
0.491
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.491
|
|
|
|
positive regulation of cell cycle g2 m phase transition
|
GO:1902751 |
5 |
0.485
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.483
|
|
|
|
histone h3 deacetylation
|
GO:0070932 |
8 |
0.482
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.477
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.475
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.457
|
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.448
|
|
|
|
histone h4 k12 acetylation
|
GO:0043983 |
2 |
0.445
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.441
|
|
|
|
positive regulation of viral process
|
GO:0048524 |
5 |
0.441
|
|
|
|
regulation of transcription involved in g1 s transition of mitotic cell cycle
|
GO:0000083 |
3 |
0.433
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.418
|
|
|
|
male meiosis i
|
GO:0007141 |
16 |
0.417
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.411
|
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.410
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.409
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.409
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.392
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.386
|
|
|
|
regulation of histone methylation
|
GO:0031060 |
30 |
0.380
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.379
|
|
|
|
regulation of dna templated transcription in response to stress
|
GO:0043620 |
9 |
0.375
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
3 |
0.372
|
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
28 |
0.372
|
|
|
|
transcription elongation from rna polymerase ii promoter
|
GO:0006368 |
9 |
0.371
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.359
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.357
|
|
|
|
negative regulation of chromosome organization
|
GO:2001251 |
30 |
0.354
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.351
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
35 |
0.346
|
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
33 |
0.345
|
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.339
|
|
|
|
cell cycle g2 m phase transition
|
GO:0044839 |
20 |
0.336
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.333
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.330
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.325
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.321
|
|
|
|
organism emergence from protective structure
|
GO:0071684 |
4 |
0.309
|
|
|
|
modification by host of symbiont morphology or physiology
|
GO:0051851 |
12 |
0.302
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.301
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.298
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.295
|
|
|
|
heart field specification
|
GO:0003128 |
6 |
0.294
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.287
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.283
|
|
|
|
positive regulation of cell proliferation involved in heart valve morphogenesis
|
GO:0003251 |
1 |
0.281
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.281
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.279
|
|
|
|
positive regulation of mitotic cell cycle phase transition
|
GO:1901992 |
17 |
0.278
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.278
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.277
|
|
|
|
viral life cycle
|
GO:0019058 |
36 |
0.277
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.272
|
|
|
|
dna templated transcription elongation
|
GO:0006354 |
13 |
0.272
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.270
|
Worm |
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.269
|
|
|
|
regulation of androgen receptor signaling pathway
|
GO:0060765 |
3 |
0.262
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.262
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.259
|
|
|
|
regulation of histone h3 k4 methylation
|
GO:0051569 |
12 |
0.252
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.248
|
|
|
|
thick ascending limb development
|
GO:0072023 |
2 |
0.248
|
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
43 |
0.245
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.244
|
Worm |
|
|
regulation of sarcomere organization
|
GO:0060297 |
4 |
0.242
|
|
|
|
immunoglobulin secretion involved in immune response
|
GO:0002380 |
2 |
0.241
|
|
|
|
metanephric dct cell differentiation
|
GO:0072240 |
3 |
0.238
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.235
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.234
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.233
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.232
|
|
|
|
epithalamus development
|
GO:0021538 |
2 |
0.230
|
|
|
|
glial cell fate commitment
|
GO:0021781 |
14 |
0.228
|
|
|
|
regulation of histone deacetylation
|
GO:0031063 |
12 |
0.225
|
|
|
|
positive regulation of g2 m transition of mitotic cell cycle
|
GO:0010971 |
5 |
0.225
|
|
|
|
inner cell mass cell proliferation
|
GO:0001833 |
15 |
0.224
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.224
|
|
|
|
negative regulation of stem cell proliferation
|
GO:2000647 |
12 |
0.223
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.223
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.220
|
|
|
|
positive regulation of cell fate commitment
|
GO:0010455 |
8 |
0.219
|
|
|
|
male meiosis
|
GO:0007140 |
37 |
0.217
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.212
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.211
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.210
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.210
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.208
|
|
|
|
negative regulation of androgen receptor signaling pathway
|
GO:0060766 |
3 |
0.207
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.204
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.202
|
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.200
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.196
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.195
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.193
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.192
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.189
|
|
|
|
neuroblast fate determination
|
GO:0007400 |
1 |
0.189
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.187
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.187
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.186
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.185
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.183
|
Worm |
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.181
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.180
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.180
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.178
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.177
|
|
|
|
positive regulation of gene silencing by mirna
|
GO:2000637 |
1 |
0.177
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.175
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.174
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.173
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.172
|
|
|
|
chromatin silencing
|
GO:0006342 |
15 |
0.171
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.167
|
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.166
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.166
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.164
|
|
|
|
regulation of peptidyl lysine acetylation
|
GO:2000756 |
22 |
0.162
|
|
|
|
dna methylation on cytosine within a cg sequence
|
GO:0010424 |
2 |
0.161
|
|
|
|
negative regulation of neural precursor cell proliferation
|
GO:2000178 |
18 |
0.158
|
|
|
|
negative regulation of cell cycle g1 s phase transition
|
GO:1902807 |
18 |
0.158
|
|
|
|
neurohypophysis development
|
GO:0021985 |
2 |
0.158
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.157
|
|
|
|
negative regulation of chromatin modification
|
GO:1903309 |
19 |
0.157
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.155
|
Human |
|
|
negative regulation of g1 s transition of mitotic cell cycle
|
GO:2000134 |
18 |
0.154
|
|
|
|
regulation of rna splicing
|
GO:0043484 |
37 |
0.154
|
|
|
|
heart trabecula formation
|
GO:0060347 |
14 |
0.147
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.147
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.145
|
|
|
|
habituation
|
GO:0046959 |
3 |
0.143
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.142
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.141
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.140
|
|
|
|
proprioception
|
GO:0019230 |
4 |
0.139
|
|
|
|
regulation of schwann cell proliferation
|
GO:0010624 |
2 |
0.139
|
|
|
|
negative regulation of ras protein signal transduction
|
GO:0046580 |
18 |
0.136
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.133
|
|
|
|
memory
|
GO:0007613 |
58 |
0.132
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.132
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.131
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.130
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.130
|
|
|
|
histone h3 k4 methylation
|
GO:0051568 |
23 |
0.129
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.128
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.127
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.126
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.125
|
|
|
|
negative regulation of calcium ion dependent exocytosis
|
GO:0045955 |
3 |
0.125
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.122
|
|
|
|
mrna transcription from rna polymerase ii promoter
|
GO:0042789 |
4 |
0.122
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.122
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
34 |
0.122
|
|
|
|
modification of morphology or physiology of other organism
|
GO:0035821 |
18 |
0.121
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.120
|
|
|
|
disaccharide metabolic process
|
GO:0005984 |
1 |
0.120
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.119
|
|
|
|
fungiform papilla morphogenesis
|
GO:0061197 |
5 |
0.118
|
|
|
|
negative regulation of circadian rhythm
|
GO:0042754 |
8 |
0.118
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.118
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.118
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.116
|
|
|
|
viral transcription
|
GO:0019083 |
3 |
0.116
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.116
|
|
|
|
regulation of gene silencing
|
GO:0060968 |
7 |
0.116
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.116
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.113
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.112
|
|
|
|
regulation of dna templated transcription elongation
|
GO:0032784 |
10 |
0.112
|
|
|
|
positive regulation of reproductive process
|
GO:2000243 |
19 |
0.111
|
|
|
|
lung cell differentiation
|
GO:0060479 |
30 |
0.111
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.110
|
|
|
|
habenula development
|
GO:0021986 |
2 |
0.109
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.109
|
|
|
|
regulation of dna damage checkpoint
|
GO:2000001 |
3 |
0.107
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.103
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.103
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.100
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.099
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
13 |
0.098
|
|
|
|
embryonic digestive tract development
|
GO:0048566 |
27 |
0.097
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.097
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.097
|
|
|
|
modification of morphology or physiology of other organism involved in symbiotic interaction
|
GO:0051817 |
16 |
0.097
|
|
|
|
dna conformation change
|
GO:0071103 |
37 |
0.096
|
|
|
|
negative regulation of neuroblast proliferation
|
GO:0007406 |
7 |
0.096
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.095
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.093
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.093
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.092
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.092
|
|
|
|
viral process
|
GO:0016032 |
41 |
0.091
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.090
|
|
|
|
receptor biosynthetic process
|
GO:0032800 |
3 |
0.090
|
|
|
|
germ cell migration
|
GO:0008354 |
8 |
0.090
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.090
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.090
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.089
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.088
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.087
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.087
|
|
|
|
dna packaging
|
GO:0006323 |
30 |
0.086
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.085
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.085
|
|
|
|
regulation of dna dependent dna replication initiation
|
GO:0030174 |
3 |
0.085
|
|
|
|
erbb signaling pathway
|
GO:0038127 |
32 |
0.085
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.085
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.083
|
|
|
|
embryonic camera type eye development
|
GO:0031076 |
36 |
0.083
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.082
|
|
|
|
positive regulation of dendrite development
|
GO:1900006 |
21 |
0.082
|
|
|
|
embryonic axis specification
|
GO:0000578 |
30 |
0.082
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.082
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.082
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
35 |
0.082
|
|
|
|
germ line stem cell division
|
GO:0042078 |
2 |
0.081
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.081
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.080
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.079
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.078
|
|
|
|
multi organism metabolic process
|
GO:0044033 |
7 |
0.078
|
|
|
|
dna methylation involved in gamete generation
|
GO:0043046 |
15 |
0.077
|
|
|
|
positive regulation of synaptic growth at neuromuscular junction
|
GO:0045887 |
1 |
0.076
|
|
|
|
ectodermal cell differentiation
|
GO:0010668 |
3 |
0.076
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.075
|
|
|
|
cell proliferation involved in heart valve morphogenesis
|
GO:0003249 |
1 |
0.074
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.073
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.072
|
|
|
|
heterochromatin assembly
|
GO:0031507 |
2 |
0.071
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.070
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.069
|
|
|
|
g2 m transition of mitotic cell cycle
|
GO:0000086 |
20 |
0.069
|
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
32 |
0.069
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.068
|
|
|
|
white fat cell differentiation
|
GO:0050872 |
15 |
0.068
|
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.068
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.067
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.067
|
|
|
|
stem cell fate commitment
|
GO:0048865 |
5 |
0.066
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.066
|
|
|
|
trophectodermal cell differentiation
|
GO:0001829 |
21 |
0.065
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.065
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.065
|
|
|
|
histone lysine demethylation
|
GO:0070076 |
13 |
0.065
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.065
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.064
|
|
|
|
inner cell mass cell differentiation
|
GO:0001826 |
7 |
0.064
|
|
|
|
secondary heart field specification
|
GO:0003139 |
6 |
0.063
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.063
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.063
|
|
|
|
histone h3 k9 dimethylation
|
GO:0036123 |
4 |
0.062
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.062
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
34 |
0.061
|
|
|
|
response to sterol
|
GO:0036314 |
4 |
0.061
|
|
|
|
negative regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032435 |
15 |
0.061
|
|
|
|
ascending thin limb development
|
GO:0072021 |
2 |
0.061
|
|
|
|
schwann cell proliferation
|
GO:0014010 |
2 |
0.061
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.061
|
|
|
|
cellular respiration
|
GO:0045333 |
38 |
0.060
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.059
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.059
|
|
|
|
zygotic determination of anterior posterior axis embryo
|
GO:0007354 |
3 |
0.059
|
|
|
|
mesodermal cell fate commitment
|
GO:0001710 |
17 |
0.059
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.058
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.058
|
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
43 |
0.057
|
|
|
|
forebrain neuron fate commitment
|
GO:0021877 |
13 |
0.057
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.057
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.056
|
|
|
|
cd4 positive cd25 positive alpha beta regulatory t cell differentiation
|
GO:0002361 |
4 |
0.056
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.056
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.056
|
|
|
|
regulation of antimicrobial humoral response
|
GO:0002759 |
3 |
0.056
|
|
|
|
formation of anatomical boundary
|
GO:0048859 |
6 |
0.056
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.055
|
|
|
|
ventricular compact myocardium morphogenesis
|
GO:0003223 |
2 |
0.055
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.055
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.055
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.054
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.054
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.054
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.054
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.054
|
|
|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.054
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.053
|
|
|
|
positive regulation of mitotic sister chromatid separation
|
GO:1901970 |
2 |
0.053
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.053
|
|
|
|
positive regulation of histone h3 k9 methylation
|
GO:0051574 |
4 |
0.053
|
|
|
|
embryonic digestive tract morphogenesis
|
GO:0048557 |
17 |
0.053
|
|
|
|
endocardial cell differentiation
|
GO:0060956 |
4 |
0.053
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.052
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.052
|
|
|
|
specification of organ identity
|
GO:0010092 |
30 |
0.052
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.052
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.052
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.052
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.051
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.051
|
|
|
|
regulation of dna binding
|
GO:0051101 |
39 |
0.051
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.051
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.050
|
|
|
|
cardiac muscle tissue growth
|
GO:0055017 |
37 |
0.050
|
|
|
|
mrna transcription
|
GO:0009299 |
4 |
0.050
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.050
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.049
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.049
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.049
|
|
|
|
neural retina development
|
GO:0003407 |
41 |
0.049
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.049
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.048
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.048
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.048
|
|
|
|
inner cell mass cell fate commitment
|
GO:0001827 |
2 |
0.048
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.048
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.047
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
29 |
0.047
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.047
|
|
|
|
regulation of gene silencing by rna
|
GO:0060966 |
5 |
0.047
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.047
|
|
|
|
positive regulation of posttranscriptional gene silencing
|
GO:0060148 |
1 |
0.046
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.046
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.046
|
|
|
|
metanephric mesenchyme morphogenesis
|
GO:0072133 |
4 |
0.046
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.046
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.046
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.046
|
|
|
|
positive regulation of protein deacetylation
|
GO:0090312 |
9 |
0.046
|
|
|
|
negative regulation of protein catabolic process
|
GO:0042177 |
36 |
0.045
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.045
|
|
|
|
kidney mesenchyme morphogenesis
|
GO:0072131 |
4 |
0.045
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.044
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.044
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.044
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.044
|
|
|
|
regulation of cardiac muscle cell proliferation
|
GO:0060043 |
23 |
0.043
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
28 |
0.043
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.043
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.043
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.043
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.043
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.043
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.043
|
|
|
|
negative regulation of dna demethylation
|
GO:1901536 |
2 |
0.042
|
|
|
|
oligosaccharide metabolic process
|
GO:0009311 |
11 |
0.042
|
|
|
|
rhombomere morphogenesis
|
GO:0021593 |
2 |
0.042
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.042
|
|
|
|
negative regulation of cellular protein catabolic process
|
GO:1903363 |
22 |
0.042
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.041
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.041
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.041
|
|
|
|
lung epithelial cell differentiation
|
GO:0060487 |
29 |
0.040
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.040
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.039
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.039
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.039
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.039
|
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
29 |
0.038
|
Human |
